CTS is a not-for-profit growth accelerator exclusively dedicated to healthtech startups. Leveraging a global network of entrepreneurs, scientists, investors, and industry leaders in technology and life sciences, CTS’s mission is to catalyze the growth of emerging health tech companies by providing tailored acceleration services at the most critical stages of early commercialization and financing for the medtech and digital health sectors.
CTS provides 100% personalized support, analyzing each startup’s needs, removing growth barriers, and connecting founders directly with the right experts. Through this individualized approach, CTS helps startups refine their value proposition, develop effective go-to-market strategies, secure early financing, and access key markets in North America, Europe, and Asia.
CTS is exclusively dedicated to supporting innovation in health technologies, covering both medtech and digital health. We work with a wide range of solutions, including medical devices, artificial intelligence, connected health, clinical software, telemedicine, diagnostics, and decision-support tools, addressing the needs of patients, healthcare professionals, and the broader health system. Our global network brings together entrepreneurs, scientists, investors, and industry leaders in technology and life sciences, creating strong connections between the Quebec and international ecosystems and fostering best practice sharing and access to innovation.
Our working groups and activities facilitate collaboration between startups, major industry players, hospitals, and institutional partners. As a not-for-profit organization, our mission is to accelerate the commercialization of safe, patient-centered, and impactful health solutions, while opening doors to key markets in North America, Europe, and Asia. CTS serves as a catalyst, empowering the health innovation ecosystem to move forward faster for the benefit of society as a whole.
As a dedicated accelerator for healthtech and medtech startups, CTS is focused on expanding its global reach and strengthening its international collaborations. We are looking to leverage the ECHAlliance community to build new strategic partnerships with innovation networks, public and private healthcare stakeholders, and industry leaders across Europe and beyond. By connecting our startups and experts to this international ecosystem, we aim to foster cross-border collaborations, share best practices, and identify opportunities for co-development, clinical validation, and market access for cutting-edge health technologies.
We would also benefit from increased visibility for our portfolio startups and alumni within the ECHAlliance network, including participation in international events, ecosystem meetings, and joint initiatives. Access to European funding programs, shared resources, and insights into market trends and regulatory pathways would greatly support our startups’ growth and facilitate their entry into European markets. Ultimately, our goal is to accelerate the impact of health innovation by working more closely with ECHAlliance members and contributing actively to the global digital health community.
